Alnylam Pharmaceuticals Inc. (A1LN34)
Market Closed
12 Jun, 19:55
B3 B3 Primary R$
72. 52
0
0%
R$
193.27B Market Cap
- P/E Ratio
- Div Yield
4,923 Volume
-3.56 Eps
R$ 72.52
Previous Close Want to track A1LN34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
A1LN34 Earnings Reports FAQ
What is the earnings per share (EPS) for A1LN34?
The current EPS is -3.56.
What is the company's earnings growth rate?
Alnylam Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Alnylam Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Alnylam Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for A1LN34 at this time, as Alnylam Pharmaceuticals Inc has no recent EPS data to calculate it.
